ArticleAmerican journal of public health2018
Marijuana Regulatory Frameworks in Four US States: An Analysis Against a Public Health Standard.
Article in American journal of public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.
- Is legalization of recreational cannabis associated with levels of use and cannabis use disorder among youth in the United States? A rapid systematic review.European child & adolescent psychiatry · 2024Pooled it
- Content Analysis of the Corporate Social Responsibility Practices of 9 Major Cannabis Companies in Canada and the US.JAMA network open · 2022Pooled it
- Assessing Responses to Cannabis Health Warnings Among Adults in U.S. Recreational States.American journal of preventive medicine · 2025Trial
- Cannabis retailers' marketing practices and compliance with state regulations: a 2025 point-of-sale audit in 5 U.S. cities.Addictive behaviors · 2026Article
- Emergency department use by individuals with and without psychosis after state-level cannabis legalization and commercialization.Nature. Mental health · 2026Article
- Noncompliance with laws to prevent polysubstance misuse: Recreational cannabis sales to apparently alcohol-intoxicated customers.Alcohol, clinical & experimental research · 2026Article
- Cannabis Marketing Restrictions and Exposure to Cannabis Marketing in Legal US Cannabis Markets: Findings From the International Cannabis Policy Study.Drug and alcohol review · 2026Article
- United States healthcare encounters for poisoning involving cannabis relative to other substances.The American journal of drug and alcohol abuse · 2026Article
- "Well, if they exist, I ignore them": A focus group study of recall and reactions to cannabis health warnings by cannabis consumers in the United States.Preventive medicine reports · 2025Article
- The Colombian Medical Cannabis Paradox: A Scoping Review of Structural Barriers and Health Inequity.International journal of environmental research and public health · 2025Article
- Perceptions of cannabis warnings and recommendations for improvement: a qualitative study with people who use cannabis from the United States.BMC public health · 2025Article
- Cannabis Retailer Communication About Cannabis Products, Health Benefits, and Risks: A Mystery Shopper Study of Licensed Retailers in Five U.S. Cities.Journal of studies on alcohol and drugs · 2024Article
- Alignment in local approaches to alcohol and cannabis control policy: A case study of California cities and counties.The International journal on drug policy · 2023Article
- Cannabis retailer marketing strategies and regulatory compliance: A surveillance study of retailers in 5 US cities.Addictive behaviors · 2023Article
- Equity in Coverage of Local Cannabis Control Policies in California, 2020‒2021.American journal of public health · 2022Article
- The Impact of Cannabis Packaging Characteristics on Perceptions and Intentions.American journal of preventive medicine · 2022Article
- A Spatiotemporal Analysis of the Association of California City and County Cannabis Policies with Cannabis Outlet Densities.Epidemiology (Cambridge, Mass.) · 2022Article
- Frequency of adolescent cannabis smoking and vaping in the United States: Trends, disparities and concurrent substance use, 2017-19.Addiction (Abingdon, England) · 2022Observational
- Rating the comparative efficacy of state-level cannabis policies on recreational cannabis markets in the United States.The International journal on drug policy · 2022Article
- Cannabis and public health-a need to reclaim the narrative.Irish journal of medical science · 2022Article
Corrections and comments
- Commented on by
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
The movement to legalize and regulate retail marijuana is growing. We examined legislation and regulations in the first 4 states to legalize recreational marijuana (Colorado, Washington, Oregon, and Alaska) to analyze whether public health best practices from tobacco and alcohol control to reduce population-level demand were being followed. Only between 34% and 51% of policies followed best practices. Marijuana regulations generally followed US alcohol policy regarding conflict of interest, taxation, education (youth-based and problematic users), warning labels, and research that does not seek to minimize consumption and the associated health effects. Application of US alcohol policies to marijuana has been challenged by some policy actors, notably those advocating public health policies modeled on tobacco control. Reversing past decisions to regulate marijuana modeled on alcohol policies will likely become increasingly difficult once these processes are set in motion and a dominant policy framework and trajectory becomes established. Designing future marijuana legislation to prioritize public health over business would make it easier to implement legalization of recreational marijuana in a way that protects health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.